Alphatec will pay the surgeon group $8 million over three annual payments of common stock. The agreement does not provide cash consulting or future royalty payments.
The device company will gain exclusive rights to the use of all intellectual property developed by the surgeon group.
More Articles on Devices:
Boston Scientific Will Reduce Workforce By Up To 1,500 Jobs
K2M, Amedica Reach European Distribution Agreement for Biomaterial Spinal Fusion Devices
Zimmer Holdings Reports Decreased Earnings, Spine Sales in Q3
